Latest Breaking News On - Secondary outcomes - Page 1 : comparemela.com

Time to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic Stroke: A Meta-Analysis | Cerebrovascular Disease | JAMA

This individual participant data meta-analysis assesses treatment time from stroke symptom onset and disability level after treatment with intravenous thromboly

Noord hollandUnited statesVan zwamJohannes kaesmacherSwiss neurological societyBoehringer ingelheimUniversity of bernEndovascular stroke centerUniversity hospital bernR foundation for statistical computingEuropean commissionInternational stroke conferenceNetherlands organization for healthEuropean stroke organisationAmsterdam university medical centersNational institutes of health stroke scale

Intravenous Vitamin C for Patients Hospitalized With COVID-19

Two randomized clinical trials were harmonized to compare the effect of vitamin C vs control on outcomes in hospitalized patients with COVID-19 who were critica

United statesNew delhiSaudi arabiaKrung thep mahanakhonWestern australiaCity ofUnited kingdomNational universitySan franciscoSouth australiaNew zealandNorthern irelandFrance generalWellington hillsNorthern territoryAr riya

Emergency Department Resuscitative Endovascular Balloon Occlusion of the Aorta

This randomized clinical trial compares the effectiveness of resuscitative endovascular balloon occlusion of the aorta and standard care in the emergency depart

United kingdomCity ofStoke on trentRedcar and clevelandNewcastle upon tyneGreater manchesterUnited kingdom generalTim stansfieldAdam brooksAbdo sattoutAnthony hudsonChris smithAlex novakDuncan bewJulian thompsonTom cowlam

Harmony Biosciences (HRMY) Presents New Secondary Data from Phase 2 signal-detection study of pitolisant

Harmony Biosciences (HRMY) Presents New Secondary Data from Phase 2 signal-detection study of pitolisant
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKumar budurFoundation for prader willi researchCompany nasdaqHarmony biosciences holdings incAmerican academy of sleep medicineHarmony biosciences holdingsPrader willi researchAberrant behavioralChief medical officerSecondary outcomesPlacebo controlled signal detectionProof of concept studyPrader willi syndromeCaregiver global impressionAberrant behavior

HARMONY BIOSCIENCES PRESENTS NEW SECONDARY OUTCOME DATA FROM PHASE 2 SIGNAL DETECTION STUDY IN PATIENTS WITH PRADER-WILLI SYNDROME

/PRNewswire/ Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and.

United statesKumar budurLuis sanayParagon biosciencesFoundation for prader willi researchExchange commissionPrnewswire harmony biosciences holdings incDrug administrationCompany nasdaqBiosciences holdingsPrader willi researchAberrant behavioralChief medical officerSecondary outcomesPlacebo controlled signal detectionProof of concept study